Topical medication cost and utilization continue to decrease in the managed population. However, in the unmanaged space we continue to see year-over-year increases in both cost and utilization. Understanding the differences in the types of topical medications dominating each space can help us to target pharmaceutical management strategies that weed out price opportunists and ensure the most appropriate care. View the video blog to learn more.
More stories
Mitchell
Article
Workers’ Comp Data: About 25% of COVID-19 Claims Have Associated Medical Costs
Data analysis by Aarthi Thiruvengadam. In 2020, the workers’ compensation industry endured many changes due to the COVID-19 pandemic, incl
Mitchell
News Release
Mitchell’s Q1 Industry Trends Report Examines the Ongoing Effects of COVID-19 and Implications for Property & Casualty Claims and Collision Repair
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the Property &
Auto Casualty
Article
Drug of the Month: Insights Into COVID-19 Vaccines and Workers' Comp
COVID-19 vaccination efforts continue to progress, after the
Workers' Comp
Article
A Shot in the Arm to Move Claims Forward During COVID
Vaccination allows Genex case managers more opportunities for vital interaction to improve case outcomesAs frontline workers, field case m
Mitchell
Article
A Look Back at 2020 Trends in Auto Insurance
It has been a year since the United States and Canada first felt the effects of COVID-19.
Mitchell
Article
Current Used Vehicle Market Conditions: Q4 2020
December 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.